Combivir and Lovaza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivir (lamivudine; zidovudine) and Lovaza (omega-3-acid ethyl esters). Common drug interactions include anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Combivir and Lovaza. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Combivir?

Combivir has active ingredients of lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 15,450 Combivir users. Check the latest studies of Combivir.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.



On Jul, 07, 2026

26 people who take Combivir and Lovaza together, and have interactions are studied.

Combivir and Lovaza drug interactions.

What are the common drug interactions of Combivir and Lovaza, by gender? *:

female:

n/a

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Impaired work ability
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Renal transplant

What are the common drug interactions of Combivir and Lovaza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal impairment (severely reduced kidney function)
  6. Renal failure (kidney dysfunction)
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Decreased activity
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Hyperkalaemia (damage to or disease of the kidney)

50-59:

  1. Chronic kidney disease
  2. Emotional distress
  3. Pain
  4. Bone density decreased
  5. Foot fracture
  6. Osteoporosis (bones weak and more likely to break)
  7. Depression
  8. Multiple injuries
  9. Renal failure (kidney dysfunction)
  10. Arthralgia (joint pain)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Emotional distress
  6. Pain
  7. Quality of life decreased
  8. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Hiv Infection: 23 people, 88.46%
  2. High Blood Pressure: 7 people, 26.92%
  3. Pain: 5 people, 19.23%
  4. Procedural Pain: 4 people, 15.38%
  5. Infection: 4 people, 15.38%
  6. Diabetes: 4 people, 15.38%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
  8. Viral Infection: 2 people, 7.69%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 7.69%
  10. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Combivir and Lovaza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Combivir and Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Combivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovaza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine and omega-3-acid ethyl esters (the active ingredients of Combivir and Lovaza, respectively), and Combivir and Lovaza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: